Results 61 to 70 of about 2,137,881 (310)

Kaplan-Meier estimate of probability of attending for first asthma review by days since intervention

, 2016
Kaplan-Meier estimate of probability of attending for first asthma review by days since ...
Geoff Packe (3604976), Kamrul Islam (430894), Gene Feder (80748), Chris Griffiths (119288), Aklak Choudhury (3605003), Jean Ramsay (3604994), Ratna Sohanpal (3604979), Stephanie Taylor (95318), Stephen Bremner (119242), Debi-Lee Vidal (3604973), Duncan Trathen (3604991), Viv Cook (3604982), Sandra Eldridge (80747), Anna Eleri Livingstone (3604988), Gillian Foster (3605006), Neil Barnes (3604997), Elizabeth Bayliss (3466778), Philip Moss (3604985), Carolyn Dawson (3605000)   +18 more
core   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine, Hallie Coltin, Maria Kondyli, Monia Marzouki, Nicolas Prud'homme, Nida Usmani, Rebecca J. Deyell, Lesleigh Abbott, Tony H. Truong, Sapna Oberoi, Ketan Kulkarni, Josée Brossard, Lynette Bowes, Paul Gibson, Sarah McKillop, Roona Sinha, Lillian Sung, Catherine Vezina, Laura Wheaton, Alexandra P. Zorzi, Marie‐Claude Pelland‐Marcotte, Thai Hoa Tran   +21 more
wiley   +1 more source

Kaplan-Meier survival estimates.

, 2022
Kaplan-Meier survival estimates.
Qing Wang (27728), Juan Liu (6492), Zhenjie Yang (4684039)   +2 more
core   +2 more sources

Kaplan-Meier survival estimate for investing and non-investing firms (small firms).

, 2016
Kaplan-Meier survival estimate for investing and non-investing firms (small firms).
Dejan Kovac (2936430), Vuk Vukovic (817607), Boris Podobnik (709142), Nikola Kleut (2936427)   +3 more
core   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak, Katarzyna Bilska, Tomasz Koziński, Jadwiga Węcławek‐Tompol, Dorota Sega‐Pondel, Radosław Chaber, Wanda Badowska, Katarzyna Rosłan, Hanna Koseła‐Paterczyk, Anna Raciborska   +9 more
wiley   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Kaplan-Meier survival estimate for Croatian firms from 1.1.2007. to 31.03.2015.

, 2016
Kaplan-Meier survival estimate for Croatian firms from 1.1.2007. to 31.03.2015.
Dejan Kovac (2936430), Vuk Vukovic (817607), Boris Podobnik (709142), Nikola Kleut (2936427)   +3 more
core   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Kaplan-Meier survival estimate of treatment outcomes by 12 months post RR/MDR-TB treatment initiation.

, 2018
Kaplan-Meier survival estimate of treatment outcomes by 12 months post RR/MDR-TB treatment initiation.
Ian Sanne (170641), Denise Evans (288201), Sydney Rosen (213204), Kamban Hirasen (3331569), Lawrence Long (320846), Rebecca Berhanu (442834)   +5 more
core   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source